Suppr超能文献

具有非 L3 形态的成熟 B 细胞急性淋巴细胞白血病中的 RUNX1 重排。

RUNX1 rearrangement in mature B-cell acute lymphoblastic leukemia with non-L3 morphology.

机构信息

Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.

出版信息

J Clin Exp Hematop. 2023 Dec 26;63(4):240-245. doi: 10.3960/jslrt.23028. Epub 2023 Oct 28.

Abstract

Mature B-cell acute lymphoblastic leukemia (ALL) is defined by the expression of light chain-restricted surface immunoglobulin (sIg) and usually has features of the leukemic phase of Burkitt lymphoma including FAB-L3 morphology and MYC rearrangement. Recently, another distinct entity in childhood mature B-cell ALL has been characterized as non-L3 morphology and KMT2A rearrangement. Here we report an unusual case of mature B-cell ALL that presented with RUNX1 rearrangement. A 65-year-old male was admitted to our department for thorough examination of leukocytosis and thrombocytopenia. The patient's bone marrow was hypercellular and infiltrated with 97.8% myeloperoxidase-negative, medium-to-large-sized blasts without cytoplasmic vacuoles. Immunophenotypes were characterized by the presence of light chain-restricted sIg and the lack of immature markers, indicating a diagnosis of mature B-cell ALL with L2 morphology: sIg-κ+, CD19+, CD20+, CD22+, CD79a+, TdT-, and CD34-. G-banding combined with spectral karyotyping showed the following complex karyotype: 45,X,der(Y;10)(p10;q10),del(13)(q?),inv(21)(p13q22.1). Fluorescence in situ hybridization revealed separated signals of RUNX1 at 21q22.1, whereas rearrangements of MYC and KMT2A were not found. To our knowledge, inv(21)(p13q22.1) involving RUNX1 is a novel cytogenetic aberration and this is the first case of mature B-cell ALL that presented with RUNX1 rearrangement. Thus, RUNX1 may be implicated in the pathogenesis of mature B-cell ALL showing non-L3 morphology without MYC rearrangement.

摘要

成熟 B 细胞急性淋巴细胞白血病(ALL)的定义是表面免疫球蛋白(sIg)的轻链受限表达,通常具有伯基特淋巴瘤白血病期的特征,包括 FAB-L3 形态学和 MYC 重排。最近,儿童成熟 B 细胞 ALL 中又出现了一种独特的实体,其特征是非 L3 形态学和 KMT2A 重排。在这里,我们报告了一例不典型的成熟 B 细胞 ALL 病例,该病例表现为 RUNX1 重排。一名 65 岁男性因白细胞增多和血小板减少到我院接受彻底检查。患者的骨髓细胞增生,浸润 97.8%的髓过氧化物酶阴性、中等至大的原始细胞,无细胞质空泡。免疫表型特征为存在轻链受限 sIg 和缺乏幼稚标志物,表明诊断为 L2 形态学的成熟 B 细胞 ALL:sIg-κ+,CD19+,CD20+,CD22+,CD79a+,TdT-和 CD34-。G 带结合光谱核型分析显示以下复杂核型:45,X,der(Y; 10)(p10; q10),del(13)(q),inv(21)(p13q22.1)。荧光原位杂交显示 RUNX1 在 21q22.1 处的分离信号,而 MYC 和 KMT2A 的重排未发现。据我们所知,inv(21)(p13q22.1)涉及 RUNX1 是一种新的细胞遗传学异常,这是首例表现为 RUNX1 重排的成熟 B 细胞 ALL 病例。因此,RUNX1 可能与非 L3 形态学且无 MYC 重排的成熟 B 细胞 ALL 的发病机制有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6c4/10861373/80ff61e815b4/jslrt-63-240-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验